Is it safe to take propranolol (beta blocker) 160mg daily during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol 160mg Daily During Pregnancy: Safety Considerations

Propranolol 160mg daily can be used during pregnancy when benefits outweigh risks, but caution is advised due to potential fetal growth restriction, particularly in the first trimester. 1

Safety Profile and Recommendations

  • Propranolol is considered a relatively safe first-line agent for chronic prophylaxis during pregnancy due to its longer record of safety compared to other antiarrhythmic medications 1
  • The FDA classifies propranolol as a Pregnancy Category C drug, indicating that it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus 2
  • Beta blockers should be avoided during the first trimester if possible, when the risk of congenital malformations is greatest 1
  • The lowest effective dose should be used initially, with dose adjustments made according to clinical response 1

Potential Adverse Effects

  • Therapy with beta blockers has been associated with intrauterine growth retardation 1
  • Neonates whose mothers received propranolol during pregnancy may exhibit:
    • Bradycardia 2, 3
    • Hypoglycemia 2, 3
    • Respiratory depression 2, 3
    • Small placenta 2

Dosing Considerations

  • The 160mg daily dose is relatively high, though this exact dose has been used successfully in pregnancy for managing fetal tachycardia 4
  • Pharmacokinetic studies show that propranolol disposition is not significantly altered during pregnancy, suggesting standard dosing approaches may be appropriate 5
  • When using propranolol for SVT management in pregnancy, it is recommended to start with the lowest effective dose and adjust according to clinical response 1

Monitoring Recommendations

  • Adequate facilities for monitoring infants at birth should be available when mothers are receiving propranolol at parturition 2
  • Serial echocardiography may be warranted, particularly during the second or third trimester when hemodynamic load is highest 1
  • Closer monitoring of fetal growth is recommended for pregnant women on beta blockers 1
  • Surveillance for fetal bradycardia should be considered throughout pregnancy 1

Comparison with Other Beta Blockers

  • Metoprolol is also considered safe during pregnancy and may be preferred by some clinicians 1
  • Atenolol should be avoided during pregnancy as it has been associated with more pronounced intrauterine growth retardation, especially when used early in pregnancy and for longer duration 1
  • The ESC guidelines specifically state that "Atenolol should not be used for any arrhythmia" during pregnancy 1

Clinical Decision-Making Algorithm

  1. Assess the clinical necessity of propranolol treatment (severity of maternal condition)
  2. Consider alternative treatments if in first trimester
  3. If propranolol is necessary:
    • Start with lowest effective dose and titrate as needed
    • Monitor fetal growth regularly via ultrasound
    • Plan for appropriate neonatal monitoring at delivery
  4. Consider switching to metoprolol if concerns about fetal growth arise
  5. Ensure adequate facilities for monitoring potential neonatal complications at birth

While propranolol 160mg daily can be used during pregnancy when clinically indicated, the potential for fetal growth restriction and neonatal complications should be carefully weighed against maternal benefits, with particular caution during the first trimester.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of propranolol on fetal tachycardia in diabetic pregnancy.

The American journal of cardiology, 1978

Research

Pharmacokinetics of propranolol during pregnancy.

European journal of clinical pharmacology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.